BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33765336)

  • 1. Stathmin expression in metastatic colorectal cancer.
    Leiphrakpam PD; Lazenby AJ; Smith LM; Brattain MG; Are C
    J Surg Oncol; 2021 May; 123(8):1764-1772. PubMed ID: 33765336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
    Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
    J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.
    Tan HT; Wu W; Ng YZ; Zhang X; Yan B; Ong CW; Tan S; Salto-Tellez M; Hooi SC; Chung MC
    J Proteome Res; 2012 Feb; 11(2):1433-45. PubMed ID: 22181002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of PRL3 expression with colorectal cancer progression.
    Leiphrakpam PD; Lazenby AJ; Smith LM; Brattain MG; Black JD; Wang J; Are C
    J Surg Oncol; 2021 Jan; 123(1):42-51. PubMed ID: 33179291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.
    Leiphrakpam PD; Lazenby AJ; Chowdhury S; Smith LM; Mathiesen M; Brattain MG; Wang J; Black JD; Are C
    J Surg Oncol; 2020 Mar; 121(3):547-560. PubMed ID: 31867736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
    Lin MX; Wen ZF; Feng ZY; He D
    Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition.
    Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB
    Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
    Qian F; Xiao J; Gai L; Zhu J
    Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer.
    Yang B; Cao L; Liu J; Xu Y; Milne G; Chan W; Heys SD; McCaig CD; Pu J
    Cancer; 2015 May; 121(10):1570-80. PubMed ID: 25603912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
    Ozawa T; Kazama S; Akiyoshi T; Murono K; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Morikawa T; Fukayama M; Watanabe T
    Ann Surg Oncol; 2014 Aug; 21(8):2650-8. PubMed ID: 24728738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.
    Shen F; Li J; Cai W; Zhu G; Gu W; Jia L; Xu B
    Oncol Rep; 2013 Sep; 30(3):1355-61. PubMed ID: 23784465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
    Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
    Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab.
    Berk V; Deniz K; Bozkurt O; Ozaslan E; Karaca H; Inanc M; Duran AO; Ozkan M
    Asian Pac J Cancer Prev; 2015; 16(14):6149-54. PubMed ID: 26320510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
    Ling H; Pickard K; Ivan C; Isella C; Ikuo M; Mitter R; Spizzo R; Bullock M; Braicu C; Pileczki V; Vincent K; Pichler M; Stiegelbauer V; Hoefler G; Almeida MI; Hsiao A; Zhang X; Primrose J; Packham G; Liu K; Bojja K; Gafà R; Xiao L; Rossi S; Song JH; Vannini I; Fanini F; Kopetz S; Zweidler-McKay P; Wang X; Ionescu C; Irimie A; Fabbri M; Lanza G; Hamilton SR; Berindan-Neagoe I; Medico E; Mirnezami A; Calin GA; Nicoloso MS
    Gut; 2016 Jun; 65(6):977-989. PubMed ID: 25804630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway.
    Zhao L; Zhang D; Shen Q; Jin M; Lin Z; Ma H; Huang S; Zhou P; Wu G; Zhang T
    Oncogene; 2019 Feb; 38(7):935-949. PubMed ID: 30202098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma].
    Cao YC; Yang F; Liu XH; Xin X; Wang CC; Geng M
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):674-8. PubMed ID: 23159080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stathmin overexpression is associated with growth, invasion and metastasis of lung adenocarcinoma.
    Yurong L; Biaoxue R; Wei L; Zongjuan M; Hongyang S; Ping F; Wenlong G; Shuanying Y; Zongfang L
    Oncotarget; 2017 Apr; 8(16):26000-26012. PubMed ID: 27494889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POLR1D promotes colorectal cancer progression and predicts poor prognosis of patients.
    Wang M; Niu W; Hu R; Wang Y; Liu Y; Liu L; Zhong J; Zhang C; You H; Zhang J; Lu L; Wei L; Xiao W
    Mol Carcinog; 2019 May; 58(5):735-748. PubMed ID: 30582221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.